Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinshukang Tablets for Coronary Artery Disease Angina (Qi Deficiency and Blood Stasis Pattern)
CTR20150438Phase 2Active
- Sponsor
- Tangshan Longshan Pharmaceutical
- Start
- Jul 2015
- Countries
- 1
01
Overview
A Phase 2 trial of Xinshukang Tablets in angina pectoris, coronary arteriosclerosis, sponsored by Tangshan Longshan Pharmaceutical. Started Jul 2015; status: active.
02
Drugs
Xinshukang Tablets
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20150438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150438.